10-K: Kimberly-Clark Reports Increased Profitability Amid Transformation Initiative in 2024
Annual Report
Kimberly-Clark's 2024 results show a significant increase in operating profit and net income, driven by higher gross margins and the sale of its PPE business, despite a slight decrease in net sales.
Summary
- Kimberly-Clark's net sales for 2024 reached $20.1 billion, a decrease of 1.8% primarily due to unfavorable currency impacts and divestitures.
- Organic sales increased by 3.2%, driven by higher pricing in hyperinflationary economies and volume/mix gains.
- Operating profit increased by 36.9% to $3.2 billion, and net income attributable to Kimberly-Clark increased by 44.3% to $2.5 billion.
- Diluted earnings per share rose by 44.9% to $7.55.
- The company announced its 2024 Transformation Initiative, expected to generate $3.0 billion in gross productivity savings and $200 million in SG&A expense reductions by the end of 2026, with total costs of approximately $1.5 billion.
- Kimberly-Clark completed the sale of its personal protective equipment (PPE) business for $635 million, recognizing a pre-tax gain of $566 million.
- The company repurchased 7.2 million shares of its common stock at a cost of $1.0 billion and increased its dividend by 3.4% in 2024.
- Capital spending is expected to be approximately $1.0 to $1.2 billion in 2025, including incremental spending from the 2024 Transformation Initiative.
Sentiment
Score: 7
Explanation: The document presents a generally positive outlook with significant improvements in profitability and strategic initiatives underway. However, it also acknowledges challenges such as currency headwinds, cost inflation, and geopolitical risks, preventing a higher score.
Positives
- Operating profit and net income saw significant increases.
- Organic sales growth indicates strong underlying demand.
- The sale of the PPE business provided a substantial gain.
- The 2024 Transformation Initiative is expected to drive significant cost savings.
- The company continues to return capital to shareholders through dividends and share repurchases.
Negatives
- Net sales decreased by 1.8% due to unfavorable currency impacts and divestitures.
- The 2024 Transformation Initiative will incur approximately $1.5 billion in pre-tax costs.
- Operations in Russia are impacted by the war in Ukraine, with potential for asset impairment.
Risks
- Significant increases in prices for raw materials, energy, and transportation could adversely affect financial results.
- Failure of key technology systems, cyberattacks, privacy breaches, or data breaches could have a material adverse effect.
- International operations are subject to foreign market risks, including changes in foreign currency exchange rates and political instability.
- Damage to the reputation of Kimberly-Clark or its brands could adversely affect the business.
- Disruptions in the supply chain or manufacturing operations could adversely affect the business.
- Climate change and other sustainability matters may adversely affect the business and operations.
- Intense competition and changes in consumer purchasing patterns could have an adverse effect on financial results.
- Government regulations and enforcement, and potential litigation, could have an adverse effect on financial results.
Future Outlook
Kimberly-Clark will continue executing its Powering Care growth strategy, focusing on pioneering innovation, optimizing margin structure, and wiring the organization for growth, with a capital allocation approach prioritizing growth investments, dividends, accretive acquisitions, and share repurchases.
Management Comments
- The 2024 Transformation Initiative is intended to improve our focus on growth and reduce our structural cost base by realigning our internal operating and management structure to streamline our global supply chain and improve the efficiency of our corporate and regional overhead cost structures.
Industry Context
Kimberly-Clark operates in a highly competitive global marketplace with well-known branded products and low-cost private label products, facing increasing concentration and the growing presence of large-format retailers and e-tailers, which puts pressure on pricing and other competitive factors.
Comparison to Industry Standards
- The document does not contain specific comparisons to industry standards or comparable companies.
- However, it mentions competition from global, regional, and local manufacturers, including private label manufacturers.
- It also notes the increasing presence of large-format retailers, discounters, and e-tailers, which suggests a competitive landscape similar to that faced by other consumer goods companies.
Legal Proceedings
- Kimberly-Clark is involved in legal proceedings relating to its former health care business, Avanos Medical, Inc., including a qui tam matter and certain subpoena and document requests from the federal government.
- The company is cooperating with the DOJ investigation concerning allegations of potential criminal and civil violations of federal laws in connection with the manufacturing, marketing and sale of surgical gowns by its former health care business.
- Kimberly-Clark is a potentially responsible party under the provisions of the U.S. federal Comprehensive Environmental Response, Compensation and Liability Act at a number of sites where hazardous substances are present.
Stakeholder Impact
- Shareholders will benefit from increased profitability and continued capital returns.
- Employees may be affected by workforce reductions under the 2024 Transformation Initiative.
- Customers and consumers may see changes in product offerings and pricing as a result of the transformation and market conditions.
- Suppliers may be impacted by changes in sourcing and supply chain management.
- Communities in regions where Kimberly-Clark operates may be affected by the company's sustainability initiatives and environmental compliance efforts.
Next Steps
- Continue executing the Powering Care growth strategy.
- Implement and finalize actions under the 2024 Transformation Initiative.
- Monitor and evaluate new legislation and guidance related to Pillar 2 tax rules.
- Progress toward 2030 Sustainability Goals.
- Manage and mitigate risks related to the war in Ukraine.
Key Dates
| Date | Description |
|---|---|
| 1872 | Kimberly-Clark Corporation was founded. |
| 1928 | Kimberly-Clark Corporation was incorporated in Delaware. |
| 1935 | Quarterly dividends have been paid continually since this year. |
| February 24, 2022 | Kimberly-Clark completed the acquisition of a majority and controlling share of Thinx Inc. |
| March 2022 | Kimberly-Clark significantly adjusted its business in Russia, curtailing media, advertising and promotional activity and suspending capital investments. |
| April 1, 2022 | Kimberly-Clark adopted highly inflationary accounting for its operations in Trkiye. |
| June 1, 2023 | Kimberly-Clark completed the sale transaction of its Neve tissue brand and related consumer and professional tissue assets in Brazil. |
| July 1, 2024 | Kimberly-Clark completed the sale transaction of its personal protective equipment (PPE) business. |
| October 1, 2024 | The transition to the new organizational structure was completed. |
| May 1, 2025 | Date of Kimberly-Clark's 2025 Annual Meeting of Stockholders. |
| End of 2026 | Expected completion date of the 2024 Transformation Initiative. |
Keywords
Kimberly-Clark, Transformation Initiative, Financial Results, Operating Profit, Net Sales, PPE Business, Organic Sales, Share Repurchase, Dividend, Risk Factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.